GeneBioTech Co (086060.KQ) Stock Price

GeneBioTech Co Price

CLOSED
5,010.00
​
Market closed

Over the last 19 years GeneBioTech Co grew revenue by 11.2% annually, reaching 90.79 B KRW. Earnings per share have grown at 1.7% per year over the last 19 years. For GeneBioTech Co, the net margin of 4.2% is up versus -0.8% a few years ago. At today's price the dividend yield works out to roughly 0.60%. The payout ratio is around 17% of earnings.

GeneBioTech Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GeneBioTech Co business model & stock analysis

Gene Bio Tech Co., Ltd. engages in the manufacture of fermented biomass. The company is headquartered in Gongju, Chungcheongnam-Do. The company went IPO on 2006-04-28. is a company mainly engaged in the production and sale of feed additives and animal drugs. Along with subsidiaries, the Company operates its business through two segments. The Additive segment is involved in the manufacturing and sale of fermented products and bio starches. The Animal Drug segment is involved in the manufacturing and sale of livestock and fish medicine. The main products include vitamins, minerals, antibiotics, nutrients, immune stimulators, digestion and absorption promoters, among others. The firm distributes its products within the domestic market and to overseas markets, including America.

Frequently asked questions about GeneBioTech Co

Converted at the current exchange rate, the GeneBioTech Co share trades at 3.37 EUR (5,010.00 KRW).

The revenue cannot currently be calculated for GeneBioTech Co.

The profit cannot currently be calculated for GeneBioTech Co.

The P/E ratio cannot be calculated for GeneBioTech Co at the moment.

The P/S cannot be calculated for GeneBioTech Co currently.

The Eulerpool Quality Score for GeneBioTech Co is 3/10.

The ISIN of GeneBioTech Co is KR7086060001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of GeneBioTech Co is 086060.KQ. The ticker symbol is used to trade GeneBioTech Co shares on the stock exchange.

Fair ValueTerminal
4,709.40 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Apr 28, 2006
ISIN
KR7086060001
Cusip
Y2684U105
Market capitalization
43.14 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
9.59
P/B Ratio
0.78
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.34 %
Dividend
Dividend yield
0.00 %
Payout Ratio
20.44 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Oct 23, 2026, 3:18 AM

GeneBioTech Co Peer Group

GeneBioTech Co FIGI

086060:KS · BBG000BHX994086060:KQ · BBG000BHX9W8

All fundamentals and in-depth analysis of GeneBioTech Co

Our stock analysis for GeneBioTech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GeneBioTech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.